Operating Profit Cambio Fecha
AbbVie USD 3.2B 914M 2023-12
Agios Pharmaceuticals USD -106277000 5.38M 2023-12
Alnylam Pharmaceuticals USD -116404000 330.27M 2023-12
Amgen USD 1.27B 819M 2023-12
Arrowhead Research USD -136545000 28.22M 2023-12
Astellas Pharma JPY 5.22B 40.57B 2023-09
AstraZeneca USD 1.95B 502M 2023-09
Bayer EUR -3594000000 2.64B 2023-09
Biogen USD 358.9M 200.1M 2023-12
BioMarin Pharmaceutical USD 14.22M 11.44M 2023-12
Bluebird Bio USD -84729000 568K 2023-09
Bristol-Myers Squibb USD 1.85B 473M 2023-12
Daiichi Sankyo JPY 51.03B 7B 2023-09
Eli Lilly USD 2.39B 1.94B 2023-12
Exelixis USD -17583000 95.43M 2023-09
Gilead Sciences USD 1.61B 1.01B 2023-12
GlaxoSmithKline GBP 1.95B 192M 2023-09
Incyte USD 187.27M 27.44M 2023-12
Ionis Pharmaceuticals USD 20.68M 166.04M 2023-12
Merck USD -1933000000 7.68B 2023-12
Moderna USD 6M 2.02B 2023-12
Nektar Therapeutics USD -44864000 5.74M 2023-09
Pfizer USD -6551000000 3.61B 2023-12
Regeneron Pharmaceuticals USD 972.9M 138.1M 2023-12
Roche Holding CHF 9.76B 3.84B 2023-06
Sarepta Therapeutics USD -48342000 16.82M 2023-09
Vertex Pharmaceuticals USD 1.04B 11.7M 2023-09



Agios Pharmaceuticals Beneficio Operativo - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2024.